PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Sep-2022 Global Colloidal Silica Market Report 2022: A $1.12 Billion Market by 2028 - Opportunities in the Widening Scope of Aqueous Colloidal Silica & Government Regulations on Use of Protective Coatings - ResearchAndMarkets.com Businesswire
09-Sep-2022 Aseptic Processing Global Market Report 2022: Rise in Awareness About Various Diseases & An Increase in Self-Medication Practices Driving Growth - ResearchAndMarkets.com Businesswire
09-Sep-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Sep-2022 TheraVet Reports Its 2022 Half-year Results and Provides an Update on the Development of Its Activities Businesswire
09-Sep-2022 ParkourSC Appoints Holly Roland as Chief Marketing Officer Businesswire
09-Sep-2022 Paysign, Inc. to Participate in the H.C. Wainwright 24th Annual Global Investment Conference Businesswire
08-Sep-2022 Charles River Laboratories to Present at Baird and Morgan Stanley Conferences Businesswire
08-Sep-2022 Zymeworks Announces Filing and Mailing of Materials for the Special Meeting to Approve Redomicile to Delaware Businesswire
08-Sep-2022 Nanobiotix: Voting Rights and Shares Capital of the Company Businesswire
08-Sep-2022 Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors Businesswire
08-Sep-2022 Pipeline Therapeutics to Participate in the UBS Virtual Biotechnology Private Company Symposium Businesswire
08-Sep-2022 MEI Pharma Reports Fiscal Year 2022 Results and Operational Highlights Businesswire
08-Sep-2022 Des études démontrent l'efficacité d'AJOVY®▼ (frémanézumab) dans le traitement de la migraine chez des patients présentant une dépression comorbide Businesswire
08-Sep-2022 ExtractionTek Stainless Files IPRs Against Gene Pool Technologies to Protect Clients Businesswire
08-Sep-2022 Studien zeigen Wirksamkeit von AJOVY®▼ (Fremanezumab) bei der Behandlung von Migräne bei Patientinnen und Patienten mit komorbider Depression Businesswire
08-Sep-2022 Dr. Jane Goodall and Vivodyne Issue Open Letter to Congressional Leaders to Include FDA Modernization Act as a Rider in the Food and Drug Amendments Act of 2022 Businesswire
08-Sep-2022 MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September Businesswire
08-Sep-2022 MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September Businesswire
08-Sep-2022 OSE Immunotherapeutics Announces Participation In Upcoming Investor Conferences Businesswire
08-Sep-2022 Global Cell Culture Market to Grow by 11.99% Annually Through 2029 - ResearchAndMarkets.com Businesswire